ADMA BIOLOGICS, INC. Treasury Stock, Value
ADMA BIOLOGICS, INC. (ADMA) had Treasury Stock, Value of $188.45 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2026-08-05
- 2026-06-30: Treasury Stock, Value $188.45M.
- 2026-03-31: Treasury Stock, Value $143.17M.
- 2025-12-31: Treasury Stock, Value $32.09M.
- 2025-09-30: Treasury Stock, Value $23.19M.
| Period end | Treasury Stock, Value |
|---|---|
| 2026-06-30 | $188.45M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $143.17M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $32.09M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $23.19M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $15.15M 10-Q · filed 2025-08-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-25 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |